Brain natriuretic peptide changes as a potential biomarker for paroxysmal atrial fibrillation in acute ischemic stroke cases
These findings suggest that ΔBNP could be a promising practical clinical biomarker for identifying PAF in patients with causally related AIS, warranting validation in larger prospective cohorts.
Authors
- Takahito Tsukamoto
- Shuhei Kobashi (ORCID: https://orcid.org/0000-0002-5285-111X)
- Tomoya Terashima (ORCID: https://orcid.org/0000-0001-9050-7101)
- Kazumichi Yoshida (ORCID: https://orcid.org/0000-0002-8898-079X)
- A. Kitamura (ORCID: https://orcid.org/0000-0002-0099-3319)
- Hiroyuki Yabata (ORCID: https://orcid.org/0000-0003-3783-7077)
- Makoto Urushitani (ORCID: https://orcid.org/0000-0003-2773-9836)
- Satoshi Shitara (ORCID: https://orcid.org/0000-0002-1207-7983)
- Nobuhiro Ogawa
- Ryota Tamura
- Ryutaro Nakamura (ORCID: https://orcid.org/0009-0004-6384-4427)
- Isamu Yamakawa
- Yoshitaka Tamaki
- Seiji Sugiyama
Institutions
- Shiga University of Medical Science (JP)
- Shiga University (JP)
Publication Details
- Journal
- Journal of Stroke and Cerebrovascular Diseases
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1016/j.jstrokecerebrovasdis.2025.108470
- Citations
- 1
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.39